Users Discontinuing Weight-Loss Injections Regain Pounds Four Times Faster Compared to Those on Conventional Diets

A recent study suggests that people who discontinue new slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who halt conventional diet and exercise regimens.

Research printed in a prominent medical journal points out that while obese people can lose substantial amounts of their body weight while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month after stopping.

"Individuals buying such drugs must be cognizant of the risk of quick rebound weight gain when the treatment is stopped," warns researcher Dr. Susan Jebb.

That rate of recovery implies a reversion to original weight in about one and a half years.

Comparing Treatments

The study, which looked at dozens of studies involving thousands of participants, compared the results of GLP-1 agonists with other pills.

Scientists emphasize that individuals who shed pounds through diet and exercise typically see a slower creep back—around 0.1 kg a month—once they finish.

Explaining the Quick Regain

Experts propose the way of the injections is key to understanding the accelerated weight return.

The injections imitate a natural hormone called glucagon-like peptide-1, which controls appetite.

"Long-term administration of the hormone levels several times higher than normal might result in the system to produce less of its own natural GLP-1, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.

"Discontinuation of this GLP-1 'fix' means hunger is uncontrolled, making excessive eating a significant risk."

A Lifelong Condition?

Health authorities suggest the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.

Professionals argue that, given the significant potential of weight regain, the therapy might need to be long-term.

This perspective is reinforced by drug manufacturers, who note that the results "emphasize the chronic character of obesity," akin to managing diseases like diabetes.

User Accounts

Users who have discontinued the jabs explain a sudden resurgence of cravings.

"It was like a switch activating and I was suddenly starving," said one woman.

This challenge is exacerbated if individuals have not developed lasting lifestyle or habit modifications during therapy.

Widespread Adoption

Figures show that millions of people in the UK have used these injections in the last 12 months, with demand remaining high.

• Adoption is higher among females compared to men.
• The middle-aged demographic shows the greatest usage rates.
• Many obtain the drugs through private prescriptions rather than the NHS.

Finally, researchers emphasize that while these medications are potent tools for shedding pounds, they are not a magic fix and long-term success hinges on combined lifestyle changes.